The common theme of departmental research programs is molecular medicine: that is, the elucidation of the pathogenesis of disease at the molecular level and the application of this knowledge to the design and implementation of novel therapies. Our established programs include cancer biology, vascular biology, genetics, molecular hemostasis, amyloidogenesis and cholesterol metabolism. Through collaborations with the Queen’s Cancer Research Institute we also have an emerging strength in translational research.
Researchers with Labs
David Berman, MD, PhD Biomarkers and therapeutic targets for bladder and prostate cancer
Scott Davey, PhD Basic and translational studies of the DNA damage response
Peter Greer, PhD Identification and validation of novel therapeutic targets in breast cancer
Harriet Feilotter, PhD, FCCMG Biomarkers to be used in the screening, diagnosis or treatment of huan diseases, including cancer
Paula James, MD Molecular hemostasis
David LeBrun, MD Molecular mechanisms of leukemogenesis
David Lillicrap, MD Molecular hemostasis
Lois Mulligan, PhD Role of the RET proto-oncogene in cancer
Christopher Nicol, PhD Cell specific roles of PPARs in breast cancer
Anna Panchenko, PhD Molecular mechanisms of cancer: detecting drivers with computational and hybrid approaches
Michael Rauh, MD, PhD Translational studies in myeloid blood cancers and innate immune tolerance
Neil Renwick, MD, PhD Translational RNA Biology
Xiaolong Yang, PhD The molecular and cellular function of tumor suppressors in human cancer
More Researchers with labs coming soon!
Tricia Cottrell, MD, PhD
Page Last Updated: 2023 August 25